LUIS
BRIEVA RUIZ
CON
Hospital Universitari de Tarragona Joan XXIII
Tarragona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Tarragona Joan XXIII (3)
2021
-
Assessing blood-based biomarkers to define a therapeutic window for natalizumab
Journal of Personalized Medicine, Vol. 11, Núm. 12
-
Direct costs of relapses in patients with relapsing-remitting multiple sclerosis
Neurology Perspectives, Vol. 1, Núm. 3, pp. 160-169
2018
-
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates
Multiple Sclerosis Journal, Vol. 24, Núm. 14, pp. 1843-1851